Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Ergo Science Corporation (OTC BB:ERGO.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Insider | Financials
Location
790 Turnpike St., Suite 205
North Andover, MA 01845
Phone: (978) 974-9474
Fax: (978) 974-0633
Email: ldescenza@ergo.com
Employees (last reported count): 1
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 31%
·Institutional: 2% (3% of float)
(10 institutions)
·Net Inst. Selling: 3.06M shares
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Ergo Science Corporation, since 1990, has been engaged in developing Ergoset tablets for the treatment of type-II diabetes and other metabolic disorders. Ergoset tablets are a low-dose, fast-release, oral formulation of bromocriptine mesylate, a dopamine agonist used to treat Parkinson's disease, acromegaly and hyperprolactinemic conditions. The Company has not received approval from the United States Food and Drug Administration (FDA) to market Ergoset. Although Ergoset is considered "approvable" by the FDA, the FDA has required, prior to granting approval, an additional clinical trial to rule out a possible increased risk of a serious adverse event with its use. The Company has consequently begun the process of attempting to sell or license its interests in Ergoset (including its intellectual property rights), as well as its other human drug-related assets.
More from Market Guide: Expanded Business Description

Financial Summary
Ergo Science Corporation engages in the development of novel treatments for metabolic disorders, including Type II diabetes and obesity, and for cancer. For the three months ended 3/31/01, revenues remained flat at $0. Net loss applicable to Common totaled $259 thousand, up from $83 thousand. Results reflect the absence of product related and licensing and supplier revenues. Net loss reflects legal costs incurred by the Company in evaluating strategic alternatives.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, after tax earnings were -393. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Pay

Thomas McWilliams, 57
Chairman
--  
David Burt, 36
Pres, CEO, Sec.
$238K
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:ERGO.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 26-Dec-2000
$0.50 
Recent Price$1.045
52-Week High
on 11-Sep-2000
$1.344
Beta0.31 
Daily Volume (3-month avg)24.7K
Daily Volume (10-day avg)16.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y]
52-Week Change-1.7%
52-Week Change
relative to S&P500
+31.9%
Share-Related Items
Market Capitalization$14.9M
Shares Outstanding14.3M
Float9.90M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$1.34 
Earnings (ttm)-$0.07 
Earnings (mrq)-$0.04 
SalesN/A 
Cash (mrq*)$1.87 
Valuation Ratios
Price/Book (mrq*)0.78 
Price/EarningsN/A 
Price/SalesN/A 
Income Statements
SalesN/A 
EBITDA (ttm*)-$1.70M
Income available to common (ttm)-$801.0K
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-1.32%
Return on Equity (ttm)-4.12%
Financial Strength
Current Ratio (mrq*)36.63 
Debt/Equity (mrq*)0 
Total Cash (mrq)$26.6M
Short Interest
As of 8-May-2001
Shares Short5,000 
Percent of Float0.1%
Shares Short
(Prior Month)
5,000 
Short Ratio0.29 
Daily Volume17.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.